Request Demo
Last update 10 Sep 2026
Insulin human biosimilar(Wockhardt Ltd.)
Last update 10 Sep 2026
Overview
Basic Info
Drug Type Biosimilar, Peptide Hormone |
Synonyms Wosulin, Wosulin Pen, Wosulin Pen Royale + [1] |
Target |
Action agonists |
Mechanism INSR agonists(Insulin receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date India (01 Oct 2003), |
Regulation- |
Login to view timeline
Related
13
Clinical Trials associated with Insulin human biosimilar(Wockhardt Ltd.)CTRI/2022/06/043563
A Prospective, Open-Label, Randomized, Parallel Group, Comparative, Multi-center, Phase IV Trial to Evaluate the Immunogenicity and Safety of Wockhardtâ??s Basal or Bolus human insulin (Wosulin R, Wosulin N and Wosulin 30/70) with Eli Lillyâ??s Basal or Bolus human insulin (Huminsulin R, Huminsulin N and Huminsulin 30/70) in Subjects with Diabetes Mellitus
CTRI/2021/05/033411
A RANDOMIZED, SINGLE CENTER, DOUBLE BLIND, TWO TREATMENT, TWO-PERIOD, CROSSOVER GLUCOSE CLAMP STUDY TO TEST FOR BIOEQUIVALENCE BETWEEN WOCKHARDTâ??S WOSULIN® 30/70 (100 IU/mL) {BIPHASIC ISOPHANE INSULIN INJECTION/ 70% HUMAN INSULIN ISOPHANE SUSPENSION AND 30% HUMAN INSULIN INJECTION (r-DNA ORIGIN)} AND HUMULIN® 70/30 (100 U/mL) {70% HUMAN INSULIN ISOPHANE SUSPENSION AND 30% HUMAN INSULIN INJECTION (rDNA origin)} IN HEALTHY SUBJECTS. - Clamp Study
CTRI/2021/04/032915
A RANDOMIZED, SINGLE CENTER, DOUBLE BLIND, TWO TREATMENT, TWO-SEQUENCE, TWO PERIOD, CROSSOVER GLUCOSE CLAMP STUDY TO TEST FOR BIOEQUIVALENCE BETWEEN WOCKHARDTâ??S WOSULIN® N (100 IU/mL) {ISOPHANE INSULIN HUMAN, SUSPENSION, r-DNA ORIGIN} AND HUMULIN® N (100 U/mL) {HUMAN INSULIN (r-DNA ORIGIN) ISOPHANE SUSPENSION}, IN HEALTHY SUBJECTS. - Clamp Study
100 Clinical Results associated with Insulin human biosimilar(Wockhardt Ltd.)
Login to view more data
100 Translational Medicine associated with Insulin human biosimilar(Wockhardt Ltd.)
Login to view more data
100 Patents (Medical) associated with Insulin human biosimilar(Wockhardt Ltd.)
Login to view more data
100 Deals associated with Insulin human biosimilar(Wockhardt Ltd.)
Login to view more data
R&D Status
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Diabetes Mellitus, Type 1 | India | 01 Oct 2003 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free